Celiac Disease Among Egyptian Children With Unexplained Short Stature
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Detect the prevalence of celiac disease in children with unexplained short stature attended at Assiut University Children Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedStudy Start
First participant enrolled
January 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedDecember 11, 2023
December 1, 2023
12 months
December 2, 2023
December 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Celiac Disease Among Egyptian Children With Unexplained Short Stature
Detect prevalence of celiac disease in children presented with unexplained short stature
Baseline
Eligibility Criteria
Children aged between 2-18 years with undetectable causes of short stature
You may qualify if:
- (1) Children aged between 2-18 years with undetectable causes of short stature whose height was \< -2 SDfor the ageandsexaccording to Z score growth references for Egyptianchildrenand adolescent growth reference and Control DiseaseCenter(CDC) charts. (2) Short children not previously screened for Celiac disease.
You may not qualify if:
- Short children with demonstrable cause such as:
- (1) Familial and constitutional short stature. (2) Chronic illness. (3) Disproportionate short stature. (4) Short stature of endocrinal origin (eg, growth hormone deficiency). (5) Turner syndrome. (6) Short stature with significant congenital anomalies. (7) Patients on gluten free diet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Voss LD, Mulligan J, Betts PR, Wilkin TJ. Poor growth in school entrants as an index of organic disease: the Wessex growth study. BMJ. 1992 Dec 5;305(6866):1400-2. doi: 10.1136/bmj.305.6866.1400.
PMID: 1486305BACKGROUNDErtekin V, Selimoglu MA, Kardas F, Aktas E. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol. 2005 Sep;39(8):689-91. doi: 10.1097/01.mcg.0000174026.26838.56.
PMID: 16082278BACKGROUNDAhmed ML, Allen AD, Sharma A, Macfarlane JA, Dunger DB. Evaluation of a district growth screening programme: the Oxford Growth Study. Arch Dis Child. 1993 Sep;69(3):361-5. doi: 10.1136/adc.69.3.361.
PMID: 7692826BACKGROUNDItzlinger A, Branchi F, Elli L, Schumann M. Gluten-Free Diet in Celiac Disease-Forever and for All? Nutrients. 2018 Nov 18;10(11):1796. doi: 10.3390/nu10111796.
PMID: 30453686BACKGROUNDJericho H, Sansotta N, Guandalini S. Extraintestinal Manifestations of Celiac Disease: Effectiveness of the Gluten-Free Diet. J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):75-79. doi: 10.1097/MPG.0000000000001420.
PMID: 28644353BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- 71515,Assiut
Study Record Dates
First Submitted
December 2, 2023
First Posted
December 11, 2023
Study Start
January 15, 2024
Primary Completion
December 31, 2024
Study Completion
March 31, 2025
Last Updated
December 11, 2023
Record last verified: 2023-12